Elevance Health Inc.
ELV · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q3 | October 20, 2026 | — | 49.23B | — | 4.93 | — |
| 2026 Q2 | July 15, 2026 | 49.83B | 48.88B | 7.45 | 6.18 | -8.54% |
| 2026 Q1 | April 22, 2026 | 49.49B | 48.20B | 12.58 | 10.68 | +0.03% |
| 2025 Q4 | January 28, 2026 | 49.31B | 49.84B | 3.33 | 3.10 | +5.86% |
| 2025 Q3 | October 21, 2025 | 50.09B | 49.38B | 6.03 | 4.98 | -1.22% |
| 2025 Q2 | July 17, 2025 | 49.42B | 48.19B | 8.84 | 9.14 | -12.22% |
| 2025 Q1 | April 22, 2025 | 48.77B | 46.30B | 11.97 | 11.21 | +2.26% |
| 2024 Q4 | January 23, 2025 | 45.44B | 44.95B | 3.84 | 3.81 | +2.72% |
| 2024 Q3 | October 17, 2024 | 45.15B | 43.47B | 8.37 | 9.70 | -10.59% |
| 2024 Q2 | July 17, 2024 | 43.65B | 42.99B | 10.12 | 9.99 | -5.82% |
| 2024 Q1 | April 18, 2024 | 42.58B | 42.49B | 10.64 | 10.54 | +3.19% |
| 2023 Q4 | January 24, 2024 | 42.65B | 42.09B | 5.62 | 5.55 | +0.32% |
| 2023 Q3 | October 18, 2023 | 42.85B | 41.97B | 8.99 | 8.45 | +0.78% |
| 2023 Q2 | July 19, 2023 | 43.67B | 41.50B | 9.04 | 8.82 | +4.40% |
| 2023 Q1 | April 19, 2023 | 42.17B | 40.83B | 9.46 | 9.26 | -5.33% |
| 2022 Q4 | January 25, 2023 | 39.93B | 39.77B | 5.23 | 5.20 | +3.57% |